Selected research
Industry Research
Urinary and Pelvic Floor Health Solution Industry Research Report 2026
Market perspective
The global Urinary and Pelvic Floor Health Solution market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Urinary and Pelvic Floor Health Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Urinary and Pelvic Floor Health Solution market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Urinary and Pelvic Floor Health Solution market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Urinary and Pelvic Floor Health Solution include Peloton Health, Elvie, Renovia, InControl Medical, PeriCoach, NeoTract, NextGen Jane, Hollister Incorporated and Zimmer Biomet, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Urinary and Pelvic Floor Health Solution market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Urinary and Pelvic Floor Health Solution.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Urinary and Pelvic Floor Health Solution Market by Company
Peloton Health
Elvie
Renovia
InControl Medical
PeriCoach
NeoTract
NextGen Jane
Hollister Incorporated
Zimmer Biomet
Joylux
Medtronic
Atlantic Therapeutics
Boston Scientific
Urinary and Pelvic Floor Health Solution Segment by Type
Urology and Pelvic Floor Health Software
Urology and Pelvic Floor Health Service
Urinary and Pelvic Floor Health Solution Segment by Application
Male
Female
Urinary and Pelvic Floor Health Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urinary and Pelvic Floor Health Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Urinary and Pelvic Floor Health Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urinary and Pelvic Floor Health Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Urinary and Pelvic Floor Health Solution companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Urology and Pelvic Floor Health Software
- Urology and Pelvic Floor Health Service
Applications
- Male
- Female
Companies covered
- Peloton Health
- Elvie
- Renovia
- InControl Medical
- PeriCoach
- NeoTract
- NextGen Jane
- Hollister Incorporated
- Zimmer Biomet
- Joylux
- Medtronic
- Atlantic Therapeutics
- Boston Scientific
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Urinary and Pelvic Floor Health Solution by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Urology and Pelvic Floor Health Software
- 2.2.3 Urology and Pelvic Floor Health Service
- 2.3 Urinary and Pelvic Floor Health Solution by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Male
- 2.3.3 Female
- 2.4 Assumptions and Limitations
3 Urinary and Pelvic Floor Health Solution Breakdown Data by Type
- 3.1 Global Urinary and Pelvic Floor Health Solution Historic Market Size by Type (2021-2026)
- 3.2 Global Urinary and Pelvic Floor Health Solution Forecasted Market Size by Type (2027-2032)
4 Urinary and Pelvic Floor Health Solution Breakdown Data by Application
- 4.1 Global Urinary and Pelvic Floor Health Solution Historic Market Size by Application (2021-2026)
- 4.2 Global Urinary and Pelvic Floor Health Solution Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Urinary and Pelvic Floor Health Solution Market Perspective (2021-2032)
- 5.2 Global Urinary and Pelvic Floor Health Solution Growth Trends by Region
- 5.2.1 Global Urinary and Pelvic Floor Health Solution Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Urinary and Pelvic Floor Health Solution Historic Market Size by Region (2021-2026)
- 5.2.3 Urinary and Pelvic Floor Health Solution Forecasted Market Size by Region (2027-2032)
- 5.3 Urinary and Pelvic Floor Health Solution Market Dynamics
- 5.3.1 Urinary and Pelvic Floor Health Solution Industry Trends
- 5.3.2 Urinary and Pelvic Floor Health Solution Market Drivers
- 5.3.3 Urinary and Pelvic Floor Health Solution Market Challenges
- 5.3.4 Urinary and Pelvic Floor Health Solution Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Urinary and Pelvic Floor Health Solution Players by Revenue
- 6.1.1 Global Top Urinary and Pelvic Floor Health Solution Players by Revenue (2021-2026)
- 6.1.2 Global Urinary and Pelvic Floor Health Solution Revenue Market Share by Players (2021-2026)
- 6.2 Global Urinary and Pelvic Floor Health Solution Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Urinary and Pelvic Floor Health Solution Head Office and Area Served
- 6.4 Global Urinary and Pelvic Floor Health Solution Players, Product Type & Application
- 6.5 Global Urinary and Pelvic Floor Health Solution Manufacturers Established Date
- 6.6 Global Urinary and Pelvic Floor Health Solution Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Urinary and Pelvic Floor Health Solution Market Size (2021-2032)
- 7.2 North America Urinary and Pelvic Floor Health Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Urinary and Pelvic Floor Health Solution Market Size by Country (2021-2026)
- 7.4 North America Urinary and Pelvic Floor Health Solution Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Urinary and Pelvic Floor Health Solution Market Size (2021-2032)
- 8.2 Europe Urinary and Pelvic Floor Health Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Urinary and Pelvic Floor Health Solution Market Size by Country (2021-2026)
- 8.4 Europe Urinary and Pelvic Floor Health Solution Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Urinary and Pelvic Floor Health Solution Market Size (2021-2032)
- 9.2 Asia-Pacific Urinary and Pelvic Floor Health Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Urinary and Pelvic Floor Health Solution Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Urinary and Pelvic Floor Health Solution Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Urinary and Pelvic Floor Health Solution Market Size (2021-2032)
- 10.2 South America Urinary and Pelvic Floor Health Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Urinary and Pelvic Floor Health Solution Market Size by Country (2021-2026)
- 10.4 South America Urinary and Pelvic Floor Health Solution Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Urinary and Pelvic Floor Health Solution Market Size (2021-2032)
- 11.2 Middle East & Africa Urinary and Pelvic Floor Health Solution Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Urinary and Pelvic Floor Health Solution Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Urinary and Pelvic Floor Health Solution Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Peloton Health
- 12.1.1 Peloton Health Company Information
- 12.1.2 Peloton Health Business Overview
- 12.1.3 Peloton Health Revenue in Urinary and Pelvic Floor Health Solution Business (2021-2026)
- 12.1.4 Peloton Health Urinary and Pelvic Floor Health Solution Product Portfolio
- 12.1.5 Peloton Health Recent Developments
- 12.2 Elvie
- 12.2.1 Elvie Company Information
- 12.2.2 Elvie Business Overview
- 12.2.3 Elvie Revenue in Urinary and Pelvic Floor Health Solution Business (2021-2026)
- 12.2.4 Elvie Urinary and Pelvic Floor Health Solution Product Portfolio
- 12.2.5 Elvie Recent Developments
- 12.3 Renovia
- 12.3.1 Renovia Company Information
- 12.3.2 Renovia Business Overview
- 12.3.3 Renovia Revenue in Urinary and Pelvic Floor Health Solution Business (2021-2026)
- 12.3.4 Renovia Urinary and Pelvic Floor Health Solution Product Portfolio
- 12.3.5 Renovia Recent Developments
- 12.4 InControl Medical
- 12.4.1 InControl Medical Company Information
- 12.4.2 InControl Medical Business Overview
- 12.4.3 InControl Medical Revenue in Urinary and Pelvic Floor Health Solution Business (2021-2026)
- 12.4.4 InControl Medical Urinary and Pelvic Floor Health Solution Product Portfolio
- 12.4.5 InControl Medical Recent Developments
- 12.5 PeriCoach
- 12.5.1 PeriCoach Company Information
- 12.5.2 PeriCoach Business Overview
- 12.5.3 PeriCoach Revenue in Urinary and Pelvic Floor Health Solution Business (2021-2026)
- 12.5.4 PeriCoach Urinary and Pelvic Floor Health Solution Product Portfolio
- 12.5.5 PeriCoach Recent Developments
- 12.6 NeoTract
- 12.6.1 NeoTract Company Information
- 12.6.2 NeoTract Business Overview
- 12.6.3 NeoTract Revenue in Urinary and Pelvic Floor Health Solution Business (2021-2026)
- 12.6.4 NeoTract Urinary and Pelvic Floor Health Solution Product Portfolio
- 12.6.5 NeoTract Recent Developments
- 12.7 NextGen Jane
- 12.7.1 NextGen Jane Company Information
- 12.7.2 NextGen Jane Business Overview
- 12.7.3 NextGen Jane Revenue in Urinary and Pelvic Floor Health Solution Business (2021-2026)
- 12.7.4 NextGen Jane Urinary and Pelvic Floor Health Solution Product Portfolio
- 12.7.5 NextGen Jane Recent Developments
- 12.8 Hollister Incorporated
- 12.8.1 Hollister Incorporated Company Information
- 12.8.2 Hollister Incorporated Business Overview
- 12.8.3 Hollister Incorporated Revenue in Urinary and Pelvic Floor Health Solution Business (2021-2026)
- 12.8.4 Hollister Incorporated Urinary and Pelvic Floor Health Solution Product Portfolio
- 12.8.5 Hollister Incorporated Recent Developments
- 12.9 Zimmer Biomet
- 12.9.1 Zimmer Biomet Company Information
- 12.9.2 Zimmer Biomet Business Overview
- 12.9.3 Zimmer Biomet Revenue in Urinary and Pelvic Floor Health Solution Business (2021-2026)
- 12.9.4 Zimmer Biomet Urinary and Pelvic Floor Health Solution Product Portfolio
- 12.9.5 Zimmer Biomet Recent Developments
- 12.10 Joylux
- 12.10.1 Joylux Company Information
- 12.10.2 Joylux Business Overview
- 12.10.3 Joylux Revenue in Urinary and Pelvic Floor Health Solution Business (2021-2026)
- 12.10.4 Joylux Urinary and Pelvic Floor Health Solution Product Portfolio
- 12.10.5 Joylux Recent Developments
- 12.11 Medtronic
- 12.11.1 Medtronic Company Information
- 12.11.2 Medtronic Business Overview
- 12.11.3 Medtronic Revenue in Urinary and Pelvic Floor Health Solution Business (2021-2026)
- 12.11.4 Medtronic Urinary and Pelvic Floor Health Solution Product Portfolio
- 12.11.5 Medtronic Recent Developments
- 12.12 Atlantic Therapeutics
- 12.12.1 Atlantic Therapeutics Company Information
- 12.12.2 Atlantic Therapeutics Business Overview
- 12.12.3 Atlantic Therapeutics Revenue in Urinary and Pelvic Floor Health Solution Business (2021-2026)
- 12.12.4 Atlantic Therapeutics Urinary and Pelvic Floor Health Solution Product Portfolio
- 12.12.5 Atlantic Therapeutics Recent Developments
- 12.13 Boston Scientific
- 12.13.1 Boston Scientific Company Information
- 12.13.2 Boston Scientific Business Overview
- 12.13.3 Boston Scientific Revenue in Urinary and Pelvic Floor Health Solution Business (2021-2026)
- 12.13.4 Boston Scientific Urinary and Pelvic Floor Health Solution Product Portfolio
- 12.13.5 Boston Scientific Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst